A study revealed that the co-administration of DOX and apigenin dwindled the expression of hexokinase 2 (HK2) and lactate dehydrogenase A (LDHA) in the human hepatocellular carcinoma cell line, HepG2. The gene discussed is LDHA; the disease is hepatocellular carcinoma.